Status:

COMPLETED

Pharmacokinetics of Progesterone in Pregnancy

Lead Sponsor:

Thomas Jefferson University

Conditions:

Progesterone

Eligibility:

FEMALE

18-55 years

Phase:

PHASE1

Brief Summary

Pharmacokinetic analysis of 200mg vaginal progesterone suppository in women with singleton pregnancies between 18 0/7- 23 6/7 weeks' gestation

Detailed Description

Prospective study of 6 women with singleton pregnancies 18 0/7- 23 6/7 weeks' gestation with no prior preterm birth or short cervix who are administered a single dose of 200mg vaginal progesterone sup...

Eligibility Criteria

Inclusion

  • ≥18 years old pregnant with singleton gestation 16 0/7 - 23 6/7 weeks
  • pre-pregnancy BMI 20-40
  • no history of prior preterm birth

Exclusion

  • history of an adverse reaction to progesterone
  • contraindication to progesterone treatment including prior or active thrombus, active hepatic disease, known adverse reaction to progesterone
  • medical comorbidity requiring medication including: hypertension, diabetes, substance abuse/methadone maintenance therapy, asthma, thyroid disease
  • major fetal anomaly diagnosed on ultrasound or known chromosomal disorder
  • multifetal gestation
  • vaginal bleeding, preterm labor, premature rupture of membranes, or clinical chorioamnionitis, at the time of enrollment or on Day 1 of study
  • any progesterone use of any form previously during the pregnancy
  • active vaginitis
  • Illicit substance use in pregnancy including cocaine, opiates, marijuana
  • abnormal pap smear/+HPV on most recent pap smear
  • known or suspected malignancy of the breast or genital organs
  • cervical length ≤25mm

Key Trial Info

Start Date :

November 6 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 30 2018

Estimated Enrollment :

6 Patients enrolled

Trial Details

Trial ID

NCT03340701

Start Date

November 6 2017

End Date

June 30 2018

Last Update

February 20 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Thomas Jefferson University Hospital

Philadelphia, Pennsylvania, United States, 19107